Skip to main content
Earnings Labs
Immix Biopharma, Inc. logo

Immix Biopharma, Inc. (IMMX)

NASDAQ·Healthcare·Biotechnology

$11.86

-7.56%

Mkt Cap $680.02M

Analyst Ratings

Buy

6

Hold

0

Sell

0

Price Target (5 analysts)

$17.00

Range $14.00$20.00

Implied Upside

+43.3%

Consensus $17.00 vs current $11.86